{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T16:01:08Z","timestamp":1778342468651,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,25]],"date-time":"2013-10-25T00:00:00Z","timestamp":1382659200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>International clinical trials are now rapidly expanding into Asia. However, the proportion of global trials is higher in South Korea compared to Japan despite implementation of similar governmental support in both countries. The difference in clinical trial environment might influence the respective physicians\u2019 attitudes and experience towards clinical trials. Therefore, we designed a questionnaire to explore how physicians conceive the issues surrounding clinical trials in both countries.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A questionnaire survey was conducted at Kyoto University Hospital (KUHP) and Seoul National University Hospital (SNUH) in 2008. The questionnaire consisted of 15 questions and 2 open-ended questions on broad key issues relating to clinical trials.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The number of responders was 301 at KUHP and 398 at SNUH. Doctors with trial experience were 196 at KUHP and 150 at SNUH. Among them, 12% (24\/196) at KUHP and 41% (61\/150) at SUNH had global trial experience. Most respondents at both institutions viewed clinical trials favorably and thought that conducting clinical trials contributed to medical advances, which would ultimately lead to new and better treatments. The main reason raised as a hindrance to conducting clinical trials was the lack of personnel support and time. Doctors at both university hospitals thought that more clinical research coordinators were required to conduct clinical trials more efficiently. KUHP doctors were driven mainly by pure academic interest or for their desire to find new treatments, while obtaining credits for board certification and co-authorship on manuscripts also served as motivation factors for doctors at SNUH.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our results revealed that there might be two different approaches to increase clinical trial activity. One is a social level approach to establish clinical trial infrastructure providing sufficient clinical research professionals. The other is an individual level approach that would provide incentives to encourage doctors to participate in and conduct clinical trials.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2288-13-130","type":"journal-article","created":{"date-parts":[[2013,10,25]],"date-time":"2013-10-25T11:13:17Z","timestamp":1382699597000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["An international survey of physicians regarding clinical trials: a comparison between Kyoto University Hospital and Seoul National University Hospital"],"prefix":"10.1186","volume":"13","author":[{"given":"Toshiko","family":"Ito-Ihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Hwa","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ock-Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Sumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo-Youn","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Narita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taichi","family":"Hatta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Kyung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyu-Jin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Minami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinori","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Yokode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,25]]},"reference":[{"key":"1185_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrd2441","volume":"7","author":"FA Thiers","year":"2008","unstructured":"Thiers FA, Sinskey AJ, Berndt ER: Trends in the globalization of clinical trials. Nat Rev Drug Discov. 2008, 7: 13-14. 10.1038\/nrd2441.","journal-title":"Nat Rev Drug Discov"},{"key":"1185_CR2","unstructured":"International Conference on Harmonisation (ICH): Guideline for good clinical practice E6(R1). http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E6_R1\/Step4\/E6_R1__Guideline.pdf,"},{"key":"1185_CR3","unstructured":"Ministry of Health, Labour and Welfare: Ordinance on GCP. http:\/\/law.e-gov.go.jp\/htmldata\/H09\/H09F03601000028.html,"},{"key":"1185_CR4","first-page":"147","volume":"11","author":"S Fukuhara","year":"1997","unstructured":"Fukuhara S, Tanabe N, Sato K, Ohashi Y, Kurokawa K: Good clinical practice in Japan before and after ICH: problems and potential impacts on clinical trials and medical practice. Int J Pharm Med. 1997, 11: 147-153.","journal-title":"Int J Pharm Med"},{"key":"1185_CR5","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1177\/009286150904300613","volume":"43","author":"J Hashimoto","year":"2009","unstructured":"Hashimoto J, Ueda E, Narukawa M: The current situation of oncology drug Lag in Japan and strategic approaches for pharmaceutical companies. Drug Inf J. 2009, 43: 757-765. 10.1177\/009286150904300613.","journal-title":"Drug Inf J"},{"key":"1185_CR6","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/S0140-6736(07)60615-1","volume":"369","author":"J McCurry","year":"2007","unstructured":"McCurry J: Japan unveils 5-year plan to boost clinical research. Lancet. 2007, 369: 1333-1336. 10.1016\/S0140-6736(07)60615-1.","journal-title":"Lancet"},{"key":"1185_CR7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/clpt.2010.190","volume":"88","author":"K Ichimaru","year":"2010","unstructured":"Ichimaru K, Toyoshima S, Uyama Y: PMDA\u2019s Challenge to accelerate clinical development and review of new drugs in Japan. Clin Pharmacol Ther. 2010, 88: 454-457. 10.1038\/clpt.2010.190.","journal-title":"Clin Pharmacol Ther"},{"key":"1185_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/jnci\/djq017","volume":"103","author":"G Sinha","year":"2010","unstructured":"Sinha G: Japan works to shorten \u201cdrug Lag,\u201cboost trials of new drugs. J Natl Cancer Inst. 2010, 103: 148-151. http:\/\/jnci.oxfordjournals.org\/content\/102\/3\/148.full.pdf,","journal-title":"J Natl Cancer Inst"},{"key":"1185_CR9","unstructured":"Pharmaceuticals and Medical Devices Agency: Drug lag estimation FY2006-FY2009. http:\/\/www.pmda.go.jp\/operations\/shonin\/druglag.html,"},{"key":"1185_CR10","volume-title":"The first interim assessment of New 5 yearly clinical trial activation plan","author":"Ministry of Health, Labour and Welfare","year":"2009","unstructured":"Ministry of Health, Labour and Welfare: The first interim assessment of New 5 yearly clinical trial activation plan. 2009, http:\/\/www.mhlw.go.jp\/stf\/shingi\/2r9852000001f1rr-att\/2r9852000001f27k.pdf,"},{"key":"1185_CR11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/009286150103500123","volume":"35","author":"H Lee","year":"2001","unstructured":"Lee H, Kim CJ, Shin SG: Changes in clinical trial practice and the working environment in the Korean pharmaceutical industry since the implementation of good clinical practice. Drug Inf J. 2001, 35: 203-210.","journal-title":"Drug Inf J"},{"key":"1185_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3346\/jkms.2003.18.1.3","volume":"18","author":"OJ Kim","year":"2003","unstructured":"Kim OJ, Park BJ, Sohn DR, Lee SM, Shin SG: Current status of the institutional review boards in Korea: constitution, operation, and policy for protection of human research participants. J Korean Med Sci. 2003, 18: 3-10.","journal-title":"J Korean Med Sci"},{"key":"1185_CR13","unstructured":"Korea national enterprise for clinical trials. http:\/\/www.konect.or.kr\/eng\/,"},{"key":"1185_CR14","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2152\/jmi.53.292","volume":"53","author":"H Yanagawa","year":"2006","unstructured":"Yanagawa H, Nishiya M, Miyamoto T, Shikishima M, Imura M, Nakanishi R, Ariuchi K, Akaishi A, Takai S, Abe S, Kisyuku M, Kageyama C, Sato C, Yamagami M, Urakawa N, Sone S, Irahara M: Clinical trials for drug approval: a pilot study of the view of doctors at Tokushima University Hospital. J Med Invest. 2006, 53: 292-296. 10.2152\/jmi.53.292.","journal-title":"J Med Invest"},{"key":"1185_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1472-6920-9-75","volume":"9","author":"E Sumi","year":"2009","unstructured":"Sumi E, Murayama T, Yokode M: A survey of attitudes toward clinical research among physicians at Kyoto University Hospital. BMC Med Educ . 2009, 9: 75-10.1186\/1472-6920-9-75.","journal-title":"BMC Med Educ"},{"key":"1185_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.cct.2004.09.004","volume":"26","author":"K Saito","year":"2005","unstructured":"Saito K, Kodama Y, Ono S, Mutoh M, Kawashima S, Fujimura A: Current status of quality in Japanese clinical trials. Contemp Clin Trials. 2005, 26: 503-509. 10.1016\/j.cct.2004.09.004.","journal-title":"Contemp Clin Trials"},{"key":"1185_CR17","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1200\/JCO.2008.21.3967","volume":"27","author":"M Takita","year":"2009","unstructured":"Takita M, Narimatsu H, Tomoko M, Kishi Y, Murashige N, Hamaki T, Kodama Y, Yuji K, Tanaka Y, Kami M: Study of newspaper reports regarding clinical trials in Japan. J Clin Oncol. 2009, 27: 2099-2101. 10.1200\/JCO.2008.21.3967.","journal-title":"J Clin Oncol"},{"key":"1185_CR18","first-page":"12","volume-title":"Nissei Res Inst Rep","author":"MJ Kim","year":"2009","unstructured":"Kim MJ: Comparison of the national healthcare insurance system in Japan and South Korea, through the developmental processes. Nissei Res Inst Rep. 2009, 12-21. http:\/\/www.nli-research.co.jp\/report\/report\/2008\/01\/repo0901-2.pdf,"},{"key":"1185_CR19","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1136\/bmj.331.7518.648","volume":"331","author":"H Nomura","year":"2005","unstructured":"Nomura H, Nakayama T: The Japanese healthcare system. Br Med J. 2005, 331: 648-649. 10.1136\/bmj.331.7518.648.","journal-title":"Br Med J"},{"key":"1185_CR20","volume-title":"WHO world health statistics","author":"World Health Organization","year":"2010","unstructured":"World Health Organization: WHO world health statistics. 2010, http:\/\/www.who.int\/whosis\/whostat\/en\/,"},{"key":"1185_CR21","unstructured":"Imamura K, Japanese Association of Pharmaceutical Medicine (JAPhMed): Recommendations on clinical research. http:\/\/japhmed.jp\/english\/JAP%EF%BD%88Med_eng_20091028_final_v2.pdf,"},{"key":"1185_CR22","volume-title":"The ethics guideline for clinical studies","author":"The Ministry of Health, Labour and Welfare of Japan","year":"2009","unstructured":"The Ministry of Health, Labour and Welfare of Japan: The ethics guideline for clinical studies. 2009, http:\/\/www.mhlw.go.jp\/general\/seido\/kousei\/i-kenkyu\/rinsyo\/dl\/shishin.pdf,"},{"key":"1185_CR23","first-page":"446","volume":"7","author":"T Murayama","year":"2010","unstructured":"Murayama T, Sumi E, Minami M, Itoh-Ihara T, Yokode M: An approach for the total amendment of 'ethical guidelines for clinical Studies\u2019 in Japan-development of a systematic educational program-[abstract]. Clin Trials. 2010, 7: 446-","journal-title":"Clin Trials"},{"key":"1185_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/136910501750035680","volume":"3","author":"G Hales","year":"2001","unstructured":"Hales G, Beveridge A, Smith D: The conflicting roles of clinicians versus investigators in HIV randomised clinical trials. Cult Health Sex. 2001, 3: 67-79. 10.1080\/136910501750035680.","journal-title":"Cult Health Sex"},{"key":"1185_CR25","unstructured":"Tomlin Z, Desalis I, Toerien M, Donovan JL: Patient advocacy and patient centredness in participant recruitment to randomized-controlled trials: implications for informed consent. Health Expect. in press"},{"key":"1185_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.5465\/AMR.1998.926617","volume":"23","author":"DM Rousseau","year":"1998","unstructured":"Rousseau DM, Sitkin SB, Burt RS, Camerer C: Not so different after all: A cross-discipline view of trust. Acad Manage Rev. 1998, 23: 393-404. 10.5465\/AMR.1998.926617.","journal-title":"Acad Manage Rev"},{"key":"1185_CR27","volume-title":"Cultures and Organizations: Software of the Mind","author":"G Hofstede","year":"1991","unstructured":"Hofstede G: Cultures and Organizations: Software of the Mind. 1991, London: McGraw-Hill Book Company"},{"key":"1185_CR28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2302\/kjm.59.104","volume":"59","author":"Y Sato","year":"2010","unstructured":"Sato Y, Koyama K: Clinical research in Japan: past, present and future. Keio J Med. 2010, 59: 104-109. 10.2302\/kjm.59.104.","journal-title":"Keio J Med"},{"key":"1185_CR29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1177\/009286150804200602","volume":"42","author":"HE Glass","year":"2008","unstructured":"Glass HE: The importance of medical innovation in an investigator\u2019s decision to take part in clinical trials. Drug Inf J. 2008, 42: 537-543.","journal-title":"Drug Inf J"},{"key":"1185_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF03256850","volume":"25","author":"HE Glass","year":"2011","unstructured":"Glass HE, Glass JM: Latin American physicians attitudes toward participation in clinical trials: a comparison with US physicians. Pharm Med. 2011, 25: 87-94. 10.1007\/BF03256850.","journal-title":"Pharm Med"},{"key":"1185_CR31","doi-asserted-by":"publisher","first-page":"182","DOI":"10.12793\/jkscpt.2012.20.2.182","volume":"20","author":"SJ Seong","year":"2012","unstructured":"Seong SJ, Lim MS, Oak S, Lee J, Park SM, Park J, Seo JJ, Lee HW, Shin SG, Park MS, Yoon YR: Results of 2012 KoNECT certification program of the human resource project. J of Korean Soc Clin Phrmacol Ther. 2012, 20: 182-194. 10.12793\/jkscpt.2012.20.2.182.","journal-title":"J of Korean Soc Clin Phrmacol Ther"},{"key":"1185_CR32","first-page":"1301","volume":"62","author":"DL Sackett","year":"2000","unstructured":"Sackett DL, Hoey J: Why randomized controlled trials fail but needn\u2019t: a new series is launched. Can Med Assoc J. 2000, 62: 1301-1302.","journal-title":"Can Med Assoc J"},{"key":"1185_CR33","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1191\/1740774504cn020xx","volume":"1","author":"J Garcia","year":"2004","unstructured":"Garcia J, Elbourne D, Snowdon C: Equipoise: a case study of the views of clinicians involved in two neonatal trials. Clin Trials. 2004, 1: 170-178. 10.1191\/1740774504cn020xx.","journal-title":"Clin Trials"},{"key":"1185_CR34","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0895-4356(99)00141-9","volume":"52","author":"S Ross","year":"1999","unstructured":"Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R: Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol. 1999, 52: 1143-1156. 10.1016\/S0895-4356(99)00141-9.","journal-title":"J Clin Epidemiol"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2288-13-130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2288-13-130\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2288-13-130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2288-13-130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T20:07:31Z","timestamp":1630613251000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/1471-2288-13-130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,25]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1185"],"URL":"https:\/\/doi.org\/10.1186\/1471-2288-13-130","relation":{},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,25]]},"assertion":[{"value":"30 July 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"130"}}